Marcin Kortylewski, PhD, discusses what research he believes is next to come in the acute myeloid leukemia space.
Marcin Kortylewski, PhD
Advertisement
Articles by Marcin Kortylewski, PhD
Marcin Kortylewski, PhD, discusses some of the goals and findings of his research on blocking STAT3 in acute myeloid leukemia cells.
Marcin Kortylewski, PhD, discusses research demonstrating blocking STAT3 in acute myeloid leukemia (AML) cells.
Advertisement
Latest Updated Articles
Research Shows Blocking STAT3 in AML May Lead to Regression of LeukemiaPublished: March 4th 2022 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
4
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
5
